These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38716486)

  • 1. Anticancer therapy at end-of-life: A retrospective cohort study.
    Singh J; Stensvold A; Turzer M; Grov EK
    Acta Oncol; 2024 May; 63():313-321. PubMed ID: 38716486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic anticancer therapy near the end of life: an analysis of factors influencing treatment in advanced tumor disease.
    Le NS; Zeybek A; Hackner K; Gottsauner-Wolf S; Groissenberger I; Jutz F; Tschurlovich L; Schediwy J; Singer J; Kreye G
    ESMO Open; 2024 Sep; 9(9):103683. PubMed ID: 39214050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospitalizations and re-hospitalizations at the end-of-life among cancer patients; a retrospective register data study.
    Singh J; Grov EK; Turzer M; Stensvold A
    BMC Palliat Care; 2024 Feb; 23(1):39. PubMed ID: 38350961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experiences with Prescribing Large Quantities of Systemic Anticancer Therapy Near Death.
    Baena-Cañada JM; Campini Bermejo A; Gámez Casado S; Rodríguez Pérez L; Quílez Cutillas A; Calvete Candenas J; Martínez Bautista MJ; Benítez Rodríguez E
    J Palliat Med; 2019 Dec; 22(12):1515-1521. PubMed ID: 31184989
    [No Abstract]   [Full Text] [Related]  

  • 5. Thirty-day mortality after systemic anticancer treatment as a real-world, quality-of-care indicator: the Northland experience.
    Ang E; Newton LV
    Intern Med J; 2018 Apr; 48(4):403-408. PubMed ID: 28872748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity of end-of-life health care and mortality after systemic anti-cancer treatment in patients with advanced lung cancer.
    Oselin K; Pisarev H; Ilau K; Kiivet RA
    BMC Cancer; 2021 Mar; 21(1):274. PubMed ID: 33722202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of molecular targeting agents and immune-checkpoint inhibitors in patients with advanced cancer who are near the end of life.
    Hiramoto S; Taniyama T; Kikuchi A; Hori T; Yoshioka A; Inoue A
    Palliat Support Care; 2021 Dec; 19(6):709-714. PubMed ID: 33729120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway.
    Anshushaug M; Gynnild MA; Kaasa S; Kvikstad A; Grønberg BH
    Acta Oncol; 2015 Mar; 54(3):395-402. PubMed ID: 25162953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated With Aggressiveness of End-of-Life Care for Lung Cancer Patients and Associated Costs of Care.
    Bylicki O; Rivière F; Tournier C; Canoui-Poitrine F; Grassin F; Margery J; Prodel M; Vainchtock A; Assié JB; Chouaïd C
    Clin Lung Cancer; 2021 May; 22(3):e320-e328. PubMed ID: 32646653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Anti-Cancer Therapy Use in Palliative Care Outpatients With Advanced Cancer.
    Wadhwa D; Hausner D; Popovic G; Pope A; Swami N; Maganti M; Zimmermann C
    J Palliat Care; 2021 Apr; 36(2):78-86. PubMed ID: 33241732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative Systemic Therapy Given near the End of Life for Metastatic Non-Small Cell Lung Cancer.
    Beaudet MÉ; Lacasse Y; Labbé C
    Curr Oncol; 2022 Feb; 29(3):1316-1325. PubMed ID: 35323312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Anticancer Treatment Near the End of Life: a Narrative Literature Review.
    Geyer T; Le NS; Groissenberger I; Jutz F; Tschurlovich L; Kreye G
    Curr Treat Options Oncol; 2023 Oct; 24(10):1328-1350. PubMed ID: 37501037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study.
    Wallington M; Saxon EB; Bomb M; Smittenaar R; Wickenden M; McPhail S; Rashbass J; Chao D; Dewar J; Talbot D; Peake M; Perren T; Wilson C; Dodwell D
    Lancet Oncol; 2016 Sep; 17(9):1203-16. PubMed ID: 27599138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative Chemotherapy Near the End of Life in Oncology Patients.
    Zhang Z; Chen ML; Gu XL; Liu MH; Zhao WW; Cheng WW
    Am J Hosp Palliat Care; 2018 Sep; 35(9):1215-1220. PubMed ID: 29529885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality within 30 days following systemic anti-cancer therapy, a review of all cases over a 4 year period in a tertiary cancer centre.
    Khoja L; McGurk A; O'Hara C; Chow S; Hasan J
    Eur J Cancer; 2015 Jan; 51(2):233-40. PubMed ID: 25500146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality within 30 days of systemic anticancer therapy at a tertiary cancer centre: assessing the safety and quality of clinical care.
    Wilson M; Mak W; Firth M; Deva S; Findlay M
    N Z Med J; 2017 Aug; 130(1460):63-72. PubMed ID: 28796772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-intensity end-of-life care among children, adolescents, and young adults with cancer who die in the hospital: A population-based study from the French national hospital database.
    Revon-Rivière G; Pauly V; Baumstarck K; Bernard C; André N; Gentet JC; Seyler C; Fond G; Orleans V; Michel G; Auquier P; Boyer L
    Cancer; 2019 Jul; 125(13):2300-2308. PubMed ID: 30913309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of systemic anticancer therapy for patients within the last 30 days of life: experience in a private hospital oncology group.
    Wein L; Rowe C; Brady B; Handolias D; Lipton L; Pook D; Stanley R; Haines I
    Intern Med J; 2017 Mar; 47(3):280-283. PubMed ID: 27658500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative care needs, symptoms, and treatment intensity along the disease trajectory in medical oncology outpatients: a retrospective chart review.
    Bükki J; Scherbel J; Stiel S; Klein C; Meidenbauer N; Ostgathe C
    Support Care Cancer; 2013 Jun; 21(6):1743-50. PubMed ID: 23344656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multicenter Retrospective Review of Systemic Anti-Cancer Treatment and Palliative Care Provided to Solid Tumor Oncology Patients in the 12 Weeks Preceding Death in Ireland.
    Mallett V; Linehan A; Burke O; Healy L; Picardo S; Kelly CM; McCaffrey J; Carney D; McDermott R; Walshe J; Kelleher F; Higgins S; Ryan K; Higgins MJ
    Am J Hosp Palliat Care; 2021 Dec; 38(12):1404-1408. PubMed ID: 33438436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.